Naloxone Hydrochloride
Product Images NDC 17478-042

5 FDA label images from Akorn · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 17478-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Nal00 0011 01)

Structural Formula (Nal00 0011 01)
Chemical structure of naloxone hydrochloride showing its molecular framework including hydroxyl groups, aromatic rings, and the hydrochloride component.*
FDA Label Image

Principal Display Panel Text For Container Label (Nal00 0011 02)

Principal Display Panel Text For Container Label (Nal00 0011 02)
Label for Naloxone Hydrochloride Injection, USP 0.4 mg/mL by Akorn Inc. The label specifies the product as a 1 mL single-dose vial for intravenous, intramuscular, or subcutaneous use. It includes directions to protect from light and features the Akorn logo, lot number, and expiration date fields.*
FDA Label Image

Principal Display Panel Text For Carton Label (Nal00 0011 03)

Principal Display Panel Text For Carton Label (Nal00 0011 03)
Naloxone Hydrochloride Injection, USP 0.4 mg/mL single-dose vials packaging label by Akorn. The label indicates 10 vials of 1 mL each for intravenous, intramuscular, or subcutaneous use. It includes dosing, storage instructions, and composition details with inactive ingredients and aseptic technique advice.*
FDA Label Image

Principal Display Panel Text For Container Label (Nal00 0011 04)

Principal Display Panel Text For Container Label (Nal00 0011 04)
Label of Naloxone Hydrochloride Injection, USP, 4 mg/10 mL (0.4 mg/mL) multi-dose vial. The label states it is for intravenous, intramuscular, or subcutaneous use, sterile and nonpyrogenic. It includes storage instructions at 20° to 25°C and advises protecting from light. Manufactured by Akorn Inc., Lake Forest, IL.*
FDA Label Image

Principal Display Panel Text For Carton Label (Nal00 0011 05)

Principal Display Panel Text For Carton Label (Nal00 0011 05)
Packaging label for Naloxone Hydrochloride Injection, USP 4 mg/10 mL (0.4 mg/mL) by Akorn, Inc. The label indicates the product is for intravenous, intramuscular, or subcutaneous use and comes in a 10 mL multi-dose vial. It includes active and inactive ingredient information, preservation details, storage instructions, and the Akorn logo with address.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.